Nova Sud Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Nova Sud Pharmaceuticals Private Limited

Nova Sud Pharmaceuticals Private Limited, a active private limited company, was established on 12 October 2007 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2007PTC055895. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.86 Cr and a paid-up capital of ₹6.86 Cr.

Formerly known as Panindia Pharma Distributors Private Limited. It upholds a compliant status. Its leadership includes Phani Srinivas Ramella (Director), Bhaskar Reddy Cherukupalli (Director), Satya Murali Krishna Kammila (Director). Past directors included Prasad Reddy Battinapatla, Parag Jain, Phani Srinivas Ramella. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.3-4-97/Q/Nr/ Within St. John Seminary Compound, Ramanthpur, Hyderabad, Telangana, 500013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PTC055895

  • Registration Number

    055895

  • Incorporation Date

    12 October 2007

  • Authorized Capital

    ₹6.86 Cr

  • Paid-Up Capital

    ₹6.86 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.86 Cr
  • Paid Up Capital ₹ 6.86 Cr
  • Company Age 18 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 72.52%
  • Profit Growth **** -206.43%
  • Ebitda **** -122.31%
  • Net Worth -2.82%
  • Total Assets -3.83%
Company report

Nova Sud Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nova Sud Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nova Sud Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Phani Srinivas Ramella Director 31 Jul 2014 Current
Bhaskar Reddy Cherukupalli Director 26 May 2024 Current
Satya Murali Krishna Kammila Director 29 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2024 Past
Pramod Abcsdd Company Secretary 15 Sep 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Director 31 Jul 2014 Past
Pramod Abcsdd Director 27 Sep 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nova Sud Pharmaceuticals.

Nova Sud Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.52% increase. The company also saw a substantial fall in profitability, with a 206.43% decrease in profit. The company's net worth dipped by a decrease of 2.82%.

Nova Sud Pharmaceuticals revenue growth over time
Nova Sud Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 72.52%
*******
*******
*******
*******
Revenue from Operations
*******
 72.52%
*******
*******
*******
*******
Total Assets
*******
 -3.83%
*******
*******
*******
*******
Profit or Loss
*******
 -206.43%
*******
*******
*******
*******
Net Worth
*******
 -2.82%
*******
*******
*******
*******
EBITDA
*******
 -122.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nova Sud Pharmaceuticals?

In 2023, Nova Sud Pharmaceuticals had a promoter holding of 100.00%. The company had 5 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nova Sud Pharmaceuticals?

Unlock and access historical data on people associated with Nova Sud Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nova Sud Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Sud Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nova Sud Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Nova Sud Pharmaceuticals Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Nova Sud Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Bhaskar Reddy Cherukupalli was appointed as a Director was appointed as a Director on 26 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    The activity Satya Murali Krishna Kammila was appointed as a Director was appointed as a Director on 29 Sep 2021 & has been associated with this company since 4 years 5 months . was completed.

  • Director Appointment

    Phani Srinivas Ramella was appointed as a Director was appointed as a Director on 31 Jul 2014 & has been associated with this company since 11 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Nova Sud Pharmaceuticals Private Limited was registered on 12 Oct 2007 with Roc Hyderabad & aged 18 years 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nova Sud Pharmaceuticals Private Limited?

The CIN of Nova Sud Pharmaceuticals Private Limited is U24232TG2007PTC055895.

Where is Nova Sud Pharmaceuticals Private Limited headquartered?

Nova Sud Pharmaceuticals Private Limited is headquartered at No.3-4-97/Q/Nr/ Within St. John Seminary Compound, Ramanthpur, Hyderabad, Telangana, 500013.

When was Nova Sud Pharmaceuticals Private Limited incorporated?

Nova Sud Pharmaceuticals Private Limited was incorporated on 12 October 2007.

Who are the current directors of Nova Sud Pharmaceuticals Private Limited?

The current directors of Nova Sud Pharmaceuticals Private Limited are

What is the primary industry of Nova Sud Pharmaceuticals Private Limited?

The primary industry of Nova Sud Pharmaceuticals Private Limited is Trade.

Is Nova Sud Pharmaceuticals Private Limited a listed company?

Nova Sud Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Nova Sud Pharmaceuticals Private Limited?

The authorized capital of Nova Sud Pharmaceuticals Private Limited is ₹6.86 Cr, and the paid-up capital is ₹6.86 Cr.

What is the compliance status of Nova Sud Pharmaceuticals Private Limited?

The compliance status of Nova Sud Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available